Roche in Singapore
Roche has had a presence in Singapore since 1973 and has since been striving to meet the needs of patients, healthcare professionals and researchers. In Singapore, we have three broad areas of operation: Pharmaceuticals, Diagnostics and Manufacturing.
In Singapore, Roche Pharmaceuticals is active in the following Disease Biology Areas:
- Metabolic disease
- Central nervous system
Many of our products ranked amongst the top selling products in the local pharmaceuticals market.
Singapore serves as the regional headquarters for Roche Diagnostics. Our regional headquarters is responsible for all aspects of sales and marketing within the Asia Pacific region (excluding Japan), for the implementation of global processes at the regional level and for company management in line with local regulations and practices.
We are committed to providing our customers with innovative, cost effective, timely and reliable diagnostic systems and solutions that will improve patient outcomes and potentially reduce healthcare costs for society.
Roche Singapore Technical Operations
Roche Technical Operations is a fully-owned Roche subsidiary and was established in Singapore in 2009. With a combined investment of approximately USD500 million, the site is comprised of two state-of-the-art facilities which use two different production technology platforms to manufacture biologic medicines. The facilities occupy approximately 12.6 hectares at the Tuas Biomedical Park.
The Singapore site is an important part of Roche’s global manufacturing network, which includes biotechnology facilities in California (USA), Penzberg (Germany) and Basel (Switzerland). Roche Singapore Technical Operations is expected to be the first company in Singapore to produce licensed biotherapeutics using recombinant DNA technologies.